Senior Vice President, Medical Sciences
Venatorx Pharmaceuticals
Malvern, PA, United States
Paul McGovern, M.D. is the Senior V.P. Medical Sciences at Venatorx Pharmaceuticals. Dr. McGovern has spent 17 years in anti-infective pharmaceutical development at Wyeth Pharmaceuticals / Pfizer, Actelion Clinical Research, Paratek Pharmaceuticals, and Venatorx Pharmaceuticals. Dr. McGovern has a B.S. from the University of Notre Dame and a M.D. from Northwestern University. He completed an Internal Medicine Residency and Infectious Diseases Fellowship at the University of Pennsylvania. Following the completion of his medical training, Dr. McGovern was a faculty member at the University of Pennsylvania prior to joining Wyeth Pharmaceuticals in 2006.
Disclosure(s): Paratek Pharmaceuticals: Stocks/Bonds (Ongoing); Venatorx Pharmaceuticals: employee (Ongoing), Stocks/Bonds (Ongoing)
2013 - Ceftibuten-ledaborbactam, an oral beta-lactam / beta-lactamase inhibitor
Saturday, October 14, 2023
8:24 AM – 8:36 AM US ET